RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Dr. Doris Rouse Joins COVID-19 Public-Private Partnership Initiative Led by National Institutes of Health

The initiative will examine the potential of a sustainable public-private partnership to address COVID-19 and future pandemics


RESEARCH TRIANGLE PARK, N.C. — Dr. Doris Rouse, vice president of global health technologies at RTI International, a nonprofit research institute, has accepted an invitation from National Institutes of Health (NIH) director Dr. Francis Collins to be a member of a new NIH cross-sectoral group that will examine the potential of a sustainable public-private partnership to address COVID-19 and to prepare for future pandemics.

The NIH-led group, consisting of 30 high-level experts and stakeholders, held its first meeting on April 3. The meeting was led by Dr. Collins, and participants included Dr. Anthony Fauci and other representatives from NIH; BARDA Director, Dr. Rick Bright; representatives from pharmaceutical companies, venture capital, the Foundation for NIH, and the U.S.(FDA) and European (EMA) regulatory agencies. The discussion resulted in a collaborative action plan to move forward rapidly and establish working groups for specific topics.

Dr. Rouse’s background includes extensive experience with the formation and operation of public-private partnerships to address global health issues. Most notably, she helped form the TB Alliance, a public-private partnership dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs. With support from Dr. Rouse and RTI, the TB Alliance received FDA approval in 2019 for a drug regimen that treats extensively drug resistant tuberculosis.

To learn more about RTI’s ongoing work related to COVID-19, visit: www.rti.org/emerging-issue/covid-19-research.